Published online Aug 27, 2026. doi: 10.4240/wjgs.117878
Revised: February 1, 2026
Accepted: May 27, 2026
Published online: August 27, 2026
Processing time: 241 Days and 16.2 Hours
Percutaneous transhepatic biliary drainage (PTBD) is a critical minimally invasive intervention for biliary obstruction, with technical success being a key determi
To identify and quantify the clinically modifiable factors predicting technical success of ultrasound-guided PTBD, and thereby to develop an evidence-based framework for procedural triage and standardization.
A total of 263 ultrasound-guided PTBD procedures performed at three tertiary hospitals (2019-2024) were retrospectively analyzed. Technical success (defined as catheter patency at 2 weeks) and complications were evaluated. Multivariate logistic regression was used to assess provider-related, patient-related, and technical factors, with statistical significance set at P < 0.05.
The cumulative success rate was 94.3% (248/263 cases), with a first-attempt success rate of 72.6% (191/263). Repeat attempts significantly increased cumulative success (P < 0.01) but did not significantly increase the overall complication rate (P = 0.415). The significant predictors in the final multivariable model included operator exper
This study proposes a preliminary framework for standardizing ultrasound-guided PTBD by identifying three actionable determinants: Operator experience (> 20 procedures), a defined reattempt limit (≤ 2 attempts), and specific anatomic-biochemical criteria (bile duct diameter ≥ 6 mm and bilirubin concentration > 340 μmol/L). The use of dedicated puncture probes is a key technical modifier. This framework translates evidence into practical decision support, providing a foundation for protocol formalization and prospective validation.
Core Tip: This multicenter study established the first evidence-based clinical decision-making framework for predicting technical success in ultrasound-guided percutaneous transhepatic biliary drainage (PTBD). Key actionable determinants were identified: Operator experience (> 20 procedures), bile duct diameter (≥ 6 mm), and the severity of obstruction (bilirubin > 340 μmol/L). The framework also defines a safe procedural limit (≤ 2 attempts) and identifies the use of de